Intellia Therapeutics
NTLA
NTLA
148 hedge funds and large institutions have $582M invested in Intellia Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 29 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
5% more funds holding
Funds holding: 141 → 148 (+7)
2.59% more ownership
Funds ownership: 72.6% → 75.19% (+2.6%)
Holders
148
Holding in Top 10
4
Calls
$3.31M
Puts
$2.4M
Top Buyers
| 1 | +$20.1M | |
| 2 | +$18.2M | |
| 3 | +$17.9M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.2M |
| 5 |
BlackRock
New York
|
+$5.35M |
Top Sellers
| 1 | -$9.87M | |
| 2 | -$9.16M | |
| 3 | -$4.57M | |
| 4 |
Citigroup
New York
|
-$4.08M |
| 5 |
Renaissance Technologies
New York
|
-$3.11M |